| Title |
Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd003193.pub4 |
| Pubmed ID | |
| Authors |
Bhavan Prasad Rai, June D Cody, Ammar Alhasso, Laurence Stewart |
| Abstract |
Overactive bladder syndrome is defined as urgency with or without urgency incontinence, usually with frequency and nocturia. Pharmacotherapy with anticholinergic drugs is often the first line medical therapy, either alone or as an adjunct to various non-pharmacological therapies after conservative options such as reducing intake of caffeine drinks have been tried. Non-pharmacologic therapies consist of bladder training, pelvic floor muscle training with or without biofeedback, behavioural modification, electrical stimulation and surgical interventions. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | 25% |
| Argentina | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 313 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Argentina | 1 | <1% |
| Belgium | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 308 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 42 | 13% |
| Other | 39 | 12% |
| Researcher | 34 | 11% |
| Student > Bachelor | 34 | 11% |
| Student > Postgraduate | 21 | 7% |
| Other | 61 | 19% |
| Unknown | 82 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 119 | 38% |
| Nursing and Health Professions | 32 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 3% |
| Psychology | 10 | 3% |
| Sports and Recreations | 9 | 3% |
| Other | 38 | 12% |
| Unknown | 95 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2023.
All research outputs
#3,054,362
of 23,582,490 outputs
Outputs from Cochrane database of systematic reviews
#5,855
of 12,744 outputs
Outputs of similar age
#30,847
of 282,805 outputs
Outputs of similar age from Cochrane database of systematic reviews
#78
of 199 outputs
Altmetric has tracked 23,582,490 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,744 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.2. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,805 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 199 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.